Patent Classification
 

Diagnostic/Detection/Prognosis, Tests/Devices, 5-HT3 Receptor Assay

1. 5-HT3 receptor assay using transgenic mammal

Diagnostic/Detection/Prognosis, Tests/Devices, AIDS/HIV

1. Viral drug susceptibility testing
    
2. Method for measuring resistance of a patient HIV-2 to protease inhibitors
    
3. Single cell analysis of HIV replication capacity and drug resistance
    
4. Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients
    
5. Method for mutation detection in HIV-1 using pol sequencing
    
6. Detection of HIV
    
7. Method for determining prognosis of HIV infected individuals
    
8. Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
    
9. Non-M, non-O HIV-1 strains, fragments and uses
    
10. Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
     
11. Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80
     
12. Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays
     
13. Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same
     
14. Method for producing recombinant cells for detecting HIV
     
15. Methods of assessing HIV integrase inhibitor therapy
     
16. Amplification of HIV-1 gag sequences for detection of sequences associated with drug-resistance mutations
     
17. Method and tool for prognosticating HIV infection in a subject by measuring soluble urokinase plasminogen activator receptor, degradation products thereof, and urokinase plasminogen activator receptor
     
18. Methods of monitoring HIV drug resistance
     
19. Method of amplifying or detecting HIV-1 RNA
     
20. Kits for detecting HIV-2
     
21. Monoclonal antibodies to human immunodeficiency virus and uses thereof
     
22. Methods for diagnosing and treating autoimmune disease
     
23. HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
     
24. Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome

Diagnostic/Detection/Prognosis, Tests/Devices, Allergy

1. Pollen allergy-related gene 513
    
2. Saliva test for detection of food allergy and intolerance
    
3. Methods for diagnosis of allergic bronchopulmonary aspergillosis
    
4. Method for diagnosing immunologic food sensitivity
    
5. Assay for evaluation of cellular response to allergens

Diagnostic/Detection/Prognosis, Tests/Devices, Alzheimer's Disease/Neurodegenerative Disease

1. Methods for diagnosing a neurodegenerative condition
    
2. Methods for diagnosis of Alzheimer's Disease in blood samples
    
3. Human brain carboxypeptidase B antibodies
    
4. Soluble cyclic analogues of .beta. amyloid peptide
    
5. Diagnostic method for alzheimer's disease based on holo-transcobalamin II
    
6. Method and kit for following neurodegenerative diseases
    
7. Methods for diagnosing a neurodegenerative condition
    
8. Diagnostic methods for drug screening for Alzheimer's disease
    
9. Method of targeting conjugate molecules to mitochondria
    
10. Ocular diagnosis of Alzheimer's Disease
     
11. Detection of alzheimer's amyloid by magnetic resonance imaging
     
12. Methods and kits for diagnosing Alzheimer's disease from a blood sample

Diagnostic/Detection/Prognosis, Tests/Devices, Angina

1. Methods and materials for diagnosing unstable angina
    
2. Methods and materials for diagnosing unstable angina

Diagnostic/Detection/Prognosis, Tests/Devices, Arthritis/Rheumatoid Arthritis/Osteoarthritis

1. Assessing rheumatoid arthritis by measuring anti-CCP and interleukin 6
    
2. Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
    
3. Genomic DNAs participating in rheumatoid arthritis, method of diagnosing the same, method of judging onset risk and diagnostic kit for detecting the same
    
4. Antibody reactive with a protein having pre-B cell growth-supporting ability
    
5. Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
    
6. Methods and materials for evaluating rheumatoid arthritis
    
7. Rheumatoid arthritis markers

Diagnostic/Detection/Prognosis, Tests/Devices, Atherosclerosis

1. Core 2 .beta.(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis
    
2. Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease
    
3. Reagents and methods for diagnosing, imaging and treating atherosclerotic disease

Diagnostic/Detection/Prognosis, Tests/Devices, Autoimmune Disease

1. Diagnostics and therapy of epstein-barr virus in autoimmune disorders
    
2. Detection of antibody mediated inflammatory auto-immune disorders
    
3. Cells expressing fusion proteins of immunoglobulins
    
4. Diagnostic drugs for autoimmune diseases

Diagnostic/Detection/Prognosis, Tests/Devices, Bacterial Overgrowth/Endotoxin/Infection

1. Peptides for detection of antibody to Ehrlichia ewingii
    
2. System for detecting infectious agents using computer-controlled automated image analysis
    
3. Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine
    
4. Method for determining the presence of bacteria resistant to cell lysing antibiotics
    
5. Method for determining the nature of an infection
    
6. Invasion assays
    
7. Method for calibrating antibiotic disk diffusion testing of microorganisms
    
8. Device and method for detecting antibiotic-inactivating enzymes
    
9. Non-invasive localization of a light-emitting conjugate in a mammal
    
10. Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells
     
11. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
12. Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
     
13. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
     
14. Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
     
15. Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics and the preparation of said conjugate
     
16. Methods and compositions for the detection of bacterial endotoxins
    
    
17. Non-invasive test for assessing bacterial overgrowth of the small intestine

Diagnostic/Detection/Prognosis, Tests/Devices, Biomarker/Biopolymer, Detecting/Using

1. Biomarkers of chronic pelvic pain syndrome
    
2. Carbon monoxide as a biomarker and therapeutic agent
    
3. Biomarkers for oxidative stress
    
4. Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons

Diagnostic/Detection/Prognosis, Tests/Devices, Blood Coagulation and Other Related Disorders

1. Vitro methods for screening for blood coagulation disorders using metal ions

Diagnostic/Detection/Prognosis, Tests/Devices, Breast Cancer/Disease

1. Compositions and methods for the therapy and diagnosis of breast cancer
    
2. Prediction of likelihood of cancer recurrence
    
3. Predicting outcome with tamoxifen in breast cancer
    
4. Breast cancer prognostic portfolio
    
5. Matriptase, a serine protease and its applications
    
6. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
    
7. Gene expression profiling in biopsied tumor tissues
    
8. Breast cancer specific gene 1
    
9. Method of diagnosing and monitoring malignant breast carcinomas
    
10. Compositions and methods for the therapy and diagnosis of breast cancer
     
11. Compositions and methods for the therapy and diagnosis of breast cancer
     
12. Method of diagnosing breast cancer using nipple fluid
     
13. Methods for reducing the risk of breast cancer in and improving the health of women
     
14. Method of identifying and treating invasive carcinomas
     
15. Compositions and methods for the treatment and diagnosis of breast cancer
     
16. Aberrantly methylated genes as markers of breast malignancy
     
17. Methods for detection and diagnosing of breast cancer
     
18. Method and antibody for imaging breast cancer
     
19. Detection and treatment of breast disease
     
20. Methods for diagnosing and evaluating cancer
     
21. Mammaglobin, a secreted mammary-specific breast cancer protein
     
22. Identifying, monitoring, and treating women for breast precancer or cancer

Diagnostic/Detection/Prognosis, Tests/Devices, Cancer/Tumor

1. RNA from cytology samples to diagnose disease
    
2. Methods for detecting and monitoring cancer using extracellular RNA
    
3. Annexin proteins and autoantibodies as serum markers for cancer
    
4. Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody
    
5. Neoepitope detection of disease using protein arrays
    
6. Phage microarray profiling of the humoral response to disease
    
7. Methods for evaluating drug-resistance gene expression in the cancer patient
    
8. Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
    
9. Marker molecules associated with lung tumors
    
10. Method for sorting tumor cells
     
11. Biomarker detection in circulating cells
     
12. Expression profile algorithm and test for cancer prognosis
     
13. Method for solution based diagnosis
     
14. Compositions and methods for the diagnosis and treatment of tumor
     
15. Method for distinguishing between head and neck squamous cell carcinoma and lung squamous cell carcinoma
     
16. System for characterization and mapping of tissue lesions
     
17. Rapid efficacy assessment method for lung cancer therapy
     
18. Alpha-fetoprotein Immu31 antibodies and fusion proteins
     
19. Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
     
20. Methods of cancer diagnosis and therapy targeted against a cancer stem line
     
21. Determining a predisposition to cancer
     
22. Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
     
23. Microparticle-based diagnostic methods
     
24. Detection and treatment of cancers of the liver
     
25. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
     
26. Use of biomolecular targets in the treatment and visualization of tumors
     
27. Sensitivity test to predict efficacy of anti-cancer therapies
     
28. Method of encapsulating metal complex within liposomes
     
29. Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
     
30. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
     
31. Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
     
32. Classifying cancers
     
33. Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
     
34. TNF binding proteins
     
35. Method for predicting tumor recurrence
     
36. Gene markers for lung cancer
     
37. Nicotinamide N-methyltransferase as a marker for colorectal cancer
     
38. Detection and treatment of cancers of the lung
     
39. ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
     
40. Imaging of drug accumulation as a guide to antitumor therapy
     
41. Method of diagnosing, monitoring, and staging lung cancer
     
42. Imaging of drug accumulation as a guide to antitumor therapy
     
43. Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression
     
44. Method of cancer screening; method of cancer treatment; and method of diabetes treatment
     
45. Method of determining cytokine dosage for myelosuppressive state
     
46. Process for determining the tumoricidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells
     
47. Methods and kits for diagnosing tumorigenicity
     
48. Gene expression profiling in biopsied tumor tissues
     
49. Detection of protein conformations in single cells
     
50. Methods of treating and detecting cancer using viruses
     
51. Prediction of likelihood of cancer recurrence
     
52. Probes for detecting tumor cells
     
53. Methods for detecting nucleic acids indicative of cancer
     
54. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
     
55. Non-invasive approach for assessing tumors in living animals
     
56. Methods for disease detection
     
57. Immunogenic cancer peptides and uses thereof
     
58. Treating cancer
     
59. Method of identifying and treating invasive carcinomas
     
60. Predicting survival of patients with squamous cell carcinoma
     
61. Methods of detecting cancer based on prostasin
     
62. Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
     
63. Cancer diagnostic method based upon DNA methylation differences
     
64. Diagnosis and treatment of malignant neoplasms
     
65. Diagnosis and treatment of malignant neoplasms
     
66. Cancerous disease modifying antibodies
     
67. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
     
68. Methods for the early diagnosis of ovarian cancer
     
69. Screen for risk for gastric adenocarcinoma
     
70. Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
     
71. Method for detecting lymphoid tissue in tumor progression
     
72. Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma
     
73. Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility
     
74. Method for screening the risk of gastric cancer
     
75. X-ray imaging of tumors with dextran carrier of platinum compounds
     
76. Recognition of tumor-specific gene products in cancer
     
77. Methods for diagnosing and evaluating cancer
     
78. Method for detecting and killing epithelial cancer cells
     
79. Annexin proteins and autoantibodies as serum markers for cancer
     
80. Prognostic evaluation of cancer
     
81. Compositions and methods for improved detection and classification of neoplasms
     
82. Identification of differentially methylated and mutated nucleic acids
     
83. Synthesis, characterization, and application of pyridylazo bioconjugates as diagnostic and therapeutic agent
     
84. Assay of YKL-40 as a marker for cancer
     
85. Method and kit for epithelial cancer screening
     
86. Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors
    
    
87. High affinity humanized anti-TAG-72 monoclonalantibodies
    
    
88. Selective killing and diagnosis of p53+ neoplastic cells
     
    
89. Methods of detecting non-small cell lung carcinoma and ovarian cancer

Diagnostic/Detection/Prognosis, Tests/Devices, Cardiovascular Related Disorders

1. Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
    
2. Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
    
3. H-FABP as early predictor of myocardial infarction
    
4. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
    
5. Method of predicting genetic risk for hypertension
    
6. Specific antibodies for diagnosing heart failure
    
7. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
    
8. Assays for diagnosis of thrombophilic disease
    
9. Drug response marker in beta-1 adrenergic receptor gene
    
10. Methods for evaluating stroke or cardiac ischemia by nucleic acid detection
     
11. Methods and materials for evaluating cardiovascular conditions

Diagnostic/Detection/Prognosis, Tests/Devices, Celiac Disease

1. Immunological assay for detection of antibodies in celiac disease

Diagnostic/Detection/Prognosis, Tests/Devices, Chlamydia

1. Compositions, methods and kits for diagnosis and treatment of Chlamydia pneumoniae infections of the skin and those associated with cutaneous T-cell lymphoma
    
2. Diagnosis and management of infection caused by Chlamydia

Diagnostic/Detection/Prognosis, Tests/Devices, Clinical Samples, Classification

1. Patient classification

Diagnostic/Detection/Prognosis, Tests/Devices, Conformationally Altered Proteins

1. Assay for compounds which affect conformationally altered proteins

Diagnostic/Detection/Prognosis, Tests/Devices, Crohn's Disease/Ulcerative Colitis

1. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
    
2. Method and test kit for measuring immunoglobulins reactive with amylase as indication of crohn's disease

Diagnostic/Detection/Prognosis, Tests/Devices, Dermatological Related Disorders

1. Method of testing for psoriasis vulgaris

Diagnostic/Detection/Prognosis, Tests/Devices, Diabetes

1. Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
    
2. OCT based method for diagnosis and therapy
    
3. Composition for measuring glucose having improved substrate specificity
    
4. Apolipoprotein biopolymer markers indicative of insulin resistance
    
5. Method and device for determining distribution of glycation of erythrocytic membranes
    
6. Method of haplotype-based genetic analysis for determining risk for developing insulin resistance and coronary artery disease
    
7. Method of cancer screening; method of cancer treatment; and method of diabetes treatment
    
8. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
    
9. Complement C3 precursor biopolymer markers predictive of type II diabetes
    
10. Antigen associated with type 1 Diabetes Mellitus
     
11. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
     
12. Method for depositing an enzyme on an electrically conductive substrate
     
13. Detecting genetic predisposition to sight-threatening diabetic retinopathy
     
14. Islet cell antigen 1851
     
15. Diagnostic screens for type 1 diabetes (IDDM)

Diagnostic/Detection/Prognosis, Tests/Devices, Disease, General

1. Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
    
2. OCT based method for diagnosis and therapy
    
3. Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes
    
4. Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment
    
5. Method for characterizing and separating molecular associates
    
6. Pathological tissue mapping
    
7. Process for discriminating between biological states based on hidden patterns from biological data
    
8. Process for analyzing annexin-V in urine, and application thereof
    
9. Methods and compositions for detection of disease

Diagnostic/Detection/Prognosis, Tests/Devices, E. Coli

1. Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
    
2. Antibodies to intimin-like proteins of E. coli

Diagnostic/Detection/Prognosis, Tests/Devices, Ehrlichiosis

1. Identification of a new ehrlichia species from a patient suffering from ehrlichiosis

Diagnostic/Detection/Prognosis, Tests/Devices, Endometriosis

1. Use of prothymosin in the diagnosis and treatment of endometriosis

Diagnostic/Detection/Prognosis, Tests/Devices, Endotoxin

1. Assays for endotoxin

Diagnostic/Detection/Prognosis, Tests/Devices, Epilepsy/Lafora Disease

1. Lafora's disease gene

Diagnostic/Detection/Prognosis, Tests/Devices, Epstein-Barr Related Disorders

1. Reagent for detecting and monitoring viral infections
    
2. Method for diagnosis of Epstein-Barr virus associated disease

Diagnostic/Detection/Prognosis, Tests/Devices, Fertility, Female/Male

1. Urine assay for ovarian reserve
    
2. Determination of endometrial receptivity toward embryo implantation
    
3. Oligonucleotides for detecting male infertility
    
4. Method for determining the fertility of mammals, especially humans

Diagnostic/Detection/Prognosis, Tests/Devices, Genetic Disorders

1. Methods of chromosome drying and spreading
    
2. Methods for detection of genetic disorders
    
3. Diagnosis of diseases associated with gene regulation
    
4. Converting diploidy to haploidy for genetic diagnosis
    
5. Molecular detection of chromosome aberrations
    
6. Screening test for the lethal genetic trait of recurrent spontaneous pregnancy loss

Diagnostic/Detection/Prognosis,  Tests/Devices, Gluconeogenesis/ Anapleurosis

1. Methods for determining gluconeogenesis, anapleurosis and pyruvate recycling

Diagnostic/Detection/Prognosis, Tests/Devices, Hearing Loss

1. Compositions to detect lesions associated with hearing loss in the cochlear gene, COCH5B2

Diagnostic/Detection/Prognosis, Tests/Devices, Heart Diseases

1. Methods of diagnosing muscle damage
    
2. Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin D receptor gene

Diagnostic/Detection/Prognosis, Tests/Devices, Hepatitis

1. Compositions and methods for detection of hepatitis A virus nucleic acid
    
2. Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay
    
3. Hepatitis B virus surface antigen mutant and methods of detection thereof
    
4. Vaccine-induced hepatitis B viral strain and uses thereof
    
5. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
    
6. Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
    
7. Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis
    
8. Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
    
9. Mosaic protein and restriction endonuclease assisted ligation method for making the same
    
10. 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof
     
11. Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
     
12. Hepatitis-C virus type 4, 5, and 6
     
13. Methods for the simultaneous detection of HCV antigens and HCV antibodies
     
14. Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
     
15. Composition and method for diagnosing auto-immune hepatitis
     
16. Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use

Diagnostic/Detection/Prognosis, Tests/Devices, Histoplasmosis

1. Diagnosis of histoplasmosis using antigens specific for H. capsulatum

Diagnostic/Detection/Prognosis,  Tests/Devices, Immunodiagnostics/Immune Disease Related Disorders

1. Methods for diagnosis and treatment of chronic immune diseases
    
2. Immunodiagnostics using particle delivery methods

Diagnostic/Detection/Prognosis,  Tests/Devices, Interferon Therapy

1. Carrier for gene detection and its use for detecting validity of interferon therapy

Diagnostic/Detection/Prognosis, Tests/Devices, Kinase Isozyme

1. Method for assaying creatine kinase isozyme activity and assay reagent

Diagnostic/Detection/Prognosis, Tests/Devices, Leukemia

1. Early leukemia diagnostics using microsphere arrays
    
2. Process for preparation of a biomarker specific for O-acetylated sialic acid useful for diagnosing, monitoring treatment outcome, and predicting relapse of lymphoblastic leukemia

Diagnostic/Detection/Prognosis, Tests/Devices, Menopause

1. Methods of diagnosing early-onset menopause

Diagnostic/Detection/Prognosis, Tests/Devices, Nanotechnology

1. Application of nanotechnology and sensor technologies for ex-vivo diagnostics

Diagnostic/Detection/Prognosis, Tests/Devices, Neurological Disorders/Injuries

1. Spatial evolution of neural activity
    
2. Diagnostic assay for transmissible spongiform encephalopathies
    
3. Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage
    
4. Detection of neural activity
    
5. Spinal muscular atrophy diagnostic methods
    
6. Antibodies specific for growth differentiation factor-7
    
7. Optical probing of neuronal connections with fluorescent indicators
    
8. Method for determining the prognosis of a patient with a neurological disease

Diagnostic/Detection/Prognosis, Tests/Devices, Neuropsychiatric/Nervous Disorders

1. Diagnosis of tauopathies
    
2. Method to determine the risk for side effects of an SSRI treatment in a person
    
3. Skin test for schizophrenia
    
4. Method of determining susceptibility to bipolar disorders
    
5. Methods for selecting a therapy for a subject suffering from schizophrenia
    
6. Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders

Diagnostic/Detection/Prognosis, Tests/Devices, Ophthalmic Diseases

1. Agents and methods for treatment and diagnosis of ocular disorders
    
2. Immortalized human corneal epithelial cell line

Diagnostic/Detection/Prognosis, Tests/Devices, Organ/Tissue Imaging/Ultrasound

1. Elongated markers for soft tissue volume identification
    
2. Method for reducing aminoisophthalic acid bisamide related impurities in preparation of non-ionic X-ray contrast agents
    
3. Method for making magnetic fluorescent core shell nanoparticles
    
4. Process for the production of a radioactive aerosol
    
5. Sensitized online BOLD-MRI imaging method
    
6. Multi-functional plasmon-resonant contrast agents for optical coherence tomography
    
7. Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol)
    
8. Contrast agents to improve gastrointestinal tract opacification during abdominal and pelvic CT scans
    
9. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
    
10. Emissive species for clinical imaging
     
11. Positive contrast MRI of magnetically tagged cells, objects, tissues
     
12. Hydrophilic polymer biomaterial having a specific magnetic resonance imaging signal and process for the preparation of said biomaterial
     
13. Composition and method for direct visualization of the human appendix
     
14. Method for determining in vivo concentration of a metabolite
     
15. Non-invasive localization of a light-emitting conjugate in a mammal
     
16. Methods for targeted drug delivery
     
17. Materials and methods for near-infrared and infrared lymph node mapping
     
18. Imaging of drug accumulation as a guide to antitumor therapy
     
19. Imaging of drug accumulation as a guide to antitumor therapy
     
20. Osmotically stabilized microbubble preparations
     
21. Mixed gas microbubble compositions
     
22. Non-invasive localization of a light-emitting conjugate in a mammal
     
23. Methods for functional kidney imaging using small dendrimer contrast agents
     
24. Methods for using annexin for detecting cell death in vivo and treating associated conditions
     
25. Transition metal complexes of n, n',n"trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use
     
26. Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
     
27. Non-covalent bioconjugates useful for diagnosis and therapy

Diagnostic/Detection/Prognosis, Tests/Devices, Ovarian Cancer

1. Detection of ovarian cancer based upon alpha-haptoglobin levels
    
2. Ovary-specific genes and proteins
    
3. Methods for the early diagnosis of ovarian cancer
    
4. Methods for the early diagnosis of ovarian cancer

Diagnostic/Detection/Prognosis, Tests/Devices, Panic Disorder

1. Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder

Diagnostic/Detection/Prognosis, Tests/Devices, Parasitic Infection

1. Antigen fragments for the diagnosis of Toxoplasma gondii
    
2. Diagnostic assays for detection of Giardia lamblia
    
3. Compositions and methods for detecting adult Taenia solium

Diagnostic/Detection/Prognosis, Tests/Devices, Pregnancy, Complications/Pre-eclampsia/Related Disorders

1. Method for predicting pregnancy-induced hypertension
    
2. Anti-metasin antibodies and their methods of use
    
3. Method and apparatus for detecting conception in animals
    
4. Compositions and methods for early pregnancy diagnosis
    
5. Predictive test for pre-eclampsia

Diagnostic/Detection/Prognosis, Tests/Devices, Prenatal Screening

1. Multi-marker screening protocol for fetal abnormalities
    
2. Biochemical test for identifying pregnancies with Down's syndrome fetus
    
3. Product and method for swelling a cell nucleus without DNA replication
    
4. Prenatal screening for Down's syndrome using hyperglycosylated gonadotropin

Diagnostic/Detection/Prognosis, Tests/Devices, Prion Related Diseases

1. Method of screening prion disease infection factor
    
2. Method of concentrating proteins from serum
    
3. Antibodies capable to selectively detect prion PrP.sup.Sc isoforms
    
4. Antibodies to a YYX epitope of a mammalian prion protein
    
5. Method for the detection of prion diseases
    
6. Diagnostic method for a transmissible spongiform encephalopathy or a prion disease
    
7. Method of preparing cow brain homogenate
    
8. Antibodies specific for native PrPsc
    
9. Models of prion disease
    
10. Immunological detection of prions
     
11. Assay for disease related conformation of a protein and isolating same

Diagnostic/Detection/Prognosis, Tests/Devices, Prostate Cancer

1. Markers of DNA copy number alteration for improved prognostication in prostate cancer
    
2. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
    
3. Compositions and methods for therapy and diagnosis of prostate cancer
    
4. Neuroendocrine marker of prostate cancer and method for producing same
    
5. Method of identifying and treating invasive carcinomas
    
6. Methods of diagnosing prostate cancer through the detection of the presence or absence of Pax 2 mRNA
    
7. Diagnostic for metastatic prostate cancer

Diagnostic/Detection/Prognosis, Tests/Devices, Pulmonary Related Disorders

1. Detecting a bacterial process in chronic rhinosinusitis
    
2. Diagnosis of chronic obstructive pulmonary disease

Diagnostic/Detection/Prognosis, Tests/Devices, Radiolabeling

1. Stimulus sensitive gel with radioisotope and methods of making
    
2. Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
    
3. Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
    
4. Site-specific labeling of disulfide-containing targeting vectors

Diagnostic/Detection/Prognosis, Tests/Devices, Receptor-Based Assay for Pathogens

1. Receptor-based assays for pathogens

Diagnostic/Detection/Prognosis, Tests/Devices, Rubella

1. Specificity in the detection of anti-rubella IGM antibodies
    
2. Specificity in the detection of anti-rubella IgM antibodies

Diagnostic/Detection/Prognosis, Tests/Devices, Sexually Transmitted Diseases/Syphilis

1. Method for detecting syphilis using synthetic antigens

Diagnostic/Detection/Prognosis, Tests/Devices, Streptococcus/Staphylococcus Infection

1. Molecular identification of Staphylococcus-genus bacteria
    
2. Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
    
3. Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
    
4. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    
5. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    
6. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
    
7. Reagent for the detection of Staphylococcus aureus by agglutination

Diagnostic/Detection/Prognosis, Tests/Devices, Stroke

1. Diagnostic assay for stroke
    
2. Method of diagnosing ischemic stroke via UCP-2 detection
    
3. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

Diagnostic/Detection/Prognosis, Tests/Devices, Toxin, Tetanus/Botulinum/Others

1. Methods for determining renal toxins
    
2. Antibodies against type a botulinum neurotoxin
    
3. High throughput assays for the proteolytic activities of clostridial neurotoxins

Diagnostic/Detection/Prognosis, Tests/Devices, Tuberculosis

1. Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
    
2. Methods, kits and assay system for detecting drug-resistant Mycobacterium tuberculosis
    
3. Mycobacterial proteins, microorganisms producing them and their use for vaccines and the detection of tuberculosis
    
4. Compounds and methods for diagnosis and immunotherapy of tuberculosis
    
5. High resolution typing system for pathogenic Mycobaterium tuberculosum
    
6. TB diagnostic based on antigens from M. tuberculosis
    
7. Compounds and methods for immunotherapy and diagnosis of tuberculosis
    
8. Compounds and methods for diagnosis of tuberculosis

Diagnostic/Detection/Prognosis, Tests/Devices, X-Ray/Light

1. Liposome containing hydrophobic iodine compound and X-ray contrast medium for radiograph comprising the liposome
    
2. Non-invasive localization of a light-emitting conjugate in a mammal
    
3. X-ray imaging of tumors with dextran carrier of platinum compounds